Hematopoietic cell transplantation for sickle cell disease: state of the art

Bibliography

• PLATT OS, BRAMBILLA DJ, ROSSE WF et al.: Mortality in sickle cell disease. Life expectancy and risk factors for early death [see comments]. N. Engl. J. Med. (1994) 330(23):1639-1644.
   PubMed Web of Science ®Google Scholar
• LEIKIN SL, GALLAGHER D, KINNEY TR et al.: Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics (1989) 84(3):500-508.
   PubMed Web of Science ®Google Scholar
• SERJEANT GR: Natural history and determinants of clinical severity of sickle cell disease. Curr. Opin. Hematol. (1995) 2(2):103-108.
   PubMedGoogle Scholar
• HEBBEL RP: Adhesive interactions of sickle erythrocytes with endothelium. J. Clin. Invest. (1997) 100(11 Suppl.):S83-S86.
   PubMed Web of Science ®Google Scholar
• MAKIS AC, HATZIMICHAEL EC, BOURANTAS KL: The role of cytokines in sickle cell disease. Ann. Hematol. (2000) 79(8):407-413.
   PubMed Web of Science ®Google Scholar
• PLATT OS, THORINGTON BD, BRAMBILLA DJ et al.: Pain in sickle cell disease. Rates and risk factors. N. Engl. J. Med. (1991) 325(1):11-16.
   PubMed Web of Science ®Google Scholar
• WALTERS MC, PATIENCE M, LEISENRING W et al.: Bone marrow transplantation for sickle cell disease. N. Engl. J. Med. (1996) 335(6):369-376.
   PubMed Web of Science ®Google Scholar
• BERNAUDIN F: [Hematopoietic stem cell graft: cure for sickle cell anemia?]. Rev. Prat. (2004) 54(14):1565-1567.
   PubMedGoogle Scholar
• WALTERS MC, STORB R, PATIENCE M et al.: Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood (2000) 95(6):1918-1924.
   PubMed Web of Science ®Google Scholar
• BRIDGES W: Cerebral vascular disease accompanying sickle cell anemia. Am. J. Pathol. (1939) 15:353-360.
   PubMedGoogle Scholar
• GASTON M, SMITH J, GALLAGHER D et al.: Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD). Control. Clin. Trials (1987) 8(4 Suppl.):131S-140S.
   PubMedGoogle Scholar
• OHENE-FREMPONG K, WEINER SJ, SLEEPER LA et al.: Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood (1998) 91(1):288-294.
   PubMed Web of Science ®Google Scholar
• ARMSTRONG FD, THOMPSON RJ JR, WANG W et al.: Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics (1996) 97(6 Pt 1):864-870.
   PubMed Web of Science ®Google Scholar
• WHITE DA, MOINUDDIN A, MCKINSTRY RC et al.: Cognitive screening for silent cerebral infarction in children with sickle cell disease. J. Pediatr. Hematol. Oncol. (2006) 28(3):166-169.
   PubMed Web of Science ®Google Scholar
• MILLER ST, MACKLIN EA, PEGELOW CH et al.: Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J. Pediatr. (2001) 139(3):385-390.
   PubMed Web of Science ®Google Scholar
• VICHINSKY EP, NEUMAYR LD, EARLES AN et al.: Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N. Engl. J. Med. (2000) 342(25):1855-1865.
   PubMed Web of Science ®Google Scholar
• VICHINSKY EP, STYLES LA, COLANGELO LH et al.: Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood (1997) 89(5):1787-1792.
   PubMed Web of Science ®Google Scholar
• GOLDEN C, STYLES L, VICHINSKY E: Acute chest syndrome and sickle cell disease. Curr. Opin. Hematol. (1998) 5(2):89-92.
   PubMedGoogle Scholar
• MACHADO RF, GLADWIN MT: Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br. J. Haematol. (2005) 129(4):449-464.
   PubMed Web of Science ®Google Scholar
• LIN EE, RODGERS GP, GLADWIN MT: Hemolytic anemia-associated pulmonary hypertension in sickle cell disease. Curr. Hematol. Rep. (2005) 4(2):117-125.
   PubMedGoogle Scholar
• AMBRUSKO SJ, GUNAWARDENA S, SAKARA A et al.: Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatr. Blood Cancer (2006) 47(7):907-913.
   Web of Science ®Google Scholar
• MILLER ST, SLEEPER LA, PEGELOW CH et al.: Prediction of adverse outcomes in children with sickle cell disease. N. Engl. J. Med. (2000) 342(2):83-89.
   PubMed Web of Science ®Google Scholar
• STEINBERG MH, ADEWOYE AH: Modifier genes and sickle cell anemia. Curr. Opin. Hematol. (2006) 13(3):131-136.
   PubMed Web of Science ®Google Scholar
• DAVIS H, MOORE RM JR, GERGEN PJ: Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep. (1997) 112(1):40-43.
   PubMed Web of Science ®Google Scholar
• FERSTER A, CORAZZA F, VERTONGEN F et al.: Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. Br. J. Haematol. (1995) 90(4):804-808.
   PubMed Web of Science ®Google Scholar
• VERMYLEN C, FERNANDEZ ROBLES E, NINANE J, CORNU G: Bone marrow transplantation in five children with sickle cell anaemia. Lancet (1988) 1(8600):1427-1428.
   PubMed Web of Science ®Google Scholar
• WALTERS MC, STORB R, PATIENCE M et al.: Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood (2000) 95(6):1918-1924.
   PubMed Web of Science ®Google Scholar
• WALTERS MC: Stem cell therapy for sickle cell disease: transplantation and gene therapy. Hematology (Am. Soc. Hematol. Educ. Program) (2005):66-73.
   Google Scholar
• JANSEN J, HANKS S, THOMPSON JM, DUGAN MJ, AKARD LP: Transplantation of hematopoietic stem cells from the peripheral blood. J. Cell. Mol. Med. (2005) 9(1):37-50.
   PubMed Web of Science ®Google Scholar
• COUBAN S, BARNETT M: The source of cells for allografting. Biol. Blood Marrow Transplant. (2003) 9(11):669-673.
   Google Scholar
• BACIGALUPO A, FRASSONI F, VAN LINT MT: Bone marrow or peripheral blood as a source of stem cells for allogeneic transplantation. Haematologica (2002) 87(8 Suppl.):4-8.
   PubMedGoogle Scholar
• ABBOUD MR, JACKSON SM, BARREDO J, BEATTY J, LAVER J: Bone marrow transplantation for sickle cell anemia. Am. J. Pediatr. Hematol. Oncol. (1994) 16(1):86-89.
   PubMedGoogle Scholar
• BERNAUDIN F, VERNANT JP, VILMER E et al.: Results of allogeneic stem cell transplant for severe sickle cell disease (SCD) in France and consideration about conditioning regimen and indications in 2002. 30th Anniversary of the National Sickle Cell Disease Program National Heart, Lung, and Blood Institute National Institutes of Health and the Sickle Cell Disease Association of America, Inc. Washington Hilton and Towers, Washington, DC, USA (17 – 21 September 2002).
   Google Scholar
• GIARDINI C, GALIMBERTI M, LUCARELLI G et al.: Bone marrow transplantation in sickle-cell anemia in Pesaro. Bone Marrow Transplant. (1993) 12:122-123.
   PubMed Web of Science ®Google Scholar
• VERMYLEN C, CORNU G, FERSTER A et al.: Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant. (1998) 22(1):1-6.
   PubMed Web of Science ®Google Scholar
• WALTERS MC, PATIENCE M, LEISENRING W et al.: Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol. Blood Marrow Transplant. (2001) 7(12):665-673.
   PubMed Web of Science ®Google Scholar
• WALTERS MC, PATIENCE M, LEISENRING W et al.: Updated results of bone marrow transplantation (BMT) for sickle cell disease (SCD): impact on CNS disease. Blood (2002) 100(11 [1 of 2]):46 (Abstract 160).
   Google Scholar
• WALTERS MC: Sickle cell anemia and hematopoietic cell transplantation: When is a pound of cure worth more than an ounce of prevention? Pediatr. Transplant. (2004) 8(Suppl. 5):33-38.
   PubMed Web of Science ®Google Scholar
• STEEN RG, HELTON KJ, HORWITZ EM et al.: Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts. Ann. Neurol. (2001) 49(2):222-229.
   PubMed Web of Science ®Google Scholar
• WOODARD P, HELTON KJ, KHAN RB et al.: Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br. J. Haematol. (2005) 129(4):550-552.
   PubMed Web of Science ®Google Scholar
• KALINYAK KA, MORRIS C, BALL WS et al.: Bone marrow transplantation in a young child with sickle cell anemia. Am. J. Hematol. (1995) 48(4):256-261.
   PubMed Web of Science ®Google Scholar
• HERNIGOU P, BERNAUDIN F, REINERT P, KUENTZ M, VERNANT JP: Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up. J. Bone Joint Surg. Am. (1997) 79(11):1726-1730.
   PubMed Web of Science ®Google Scholar
• FERSTER A, BUJAN W, CORAZZA F et al.: Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood (1993) 81(4):1102-1105.
   PubMed Web of Science ®Google Scholar
• WALTERS MC, PATIENCE M, LEISENRING W et al.: Barriers to bone marrow transplantation for sickle cell anemia. Biol. Blood Marrow Transplant. (1996) 2(2):100-104.
   PubMedGoogle Scholar
• KODISH E, LANTOS J, STOCKING C et al.: Bone marrow transplantation for sickle cell disease. A study of parents’ decisions. N. Engl. J. Med. (1991) 325(19):1349-1353.
   PubMed Web of Science ®Google Scholar
• VAN BESIEN K, KOSHY M, ANDERSON-SHAW L et al.: Allogeneic stem cell transplantation for sickle cell disease. A study of patients’ decisions. Bone Marrow Transplant. (2001) 28(6):545-549.
   PubMed Web of Science ®Google Scholar
• SHIMONI A, NAGLER A: Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience. Curr. Hematol. Rep. (2004) 3(4):242-248.
   PubMedGoogle Scholar
• RESNICK IB, SHAPIRA MY, SLAVIN S: Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Transpl. Immunol. (2005) 14(3-4):207-219.
   PubMed Web of Science ®Google Scholar
• BARON F, SANDMAIER BM: Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning. Curr. Opin. Hematol. (2005) 12(6):435-443.
   PubMed Web of Science ®Google Scholar
• STORB RF, LUCARELLI G, MCSWEENEY PA, CHILDS RW: Hematopoietic cell transplantation for benign hematological disorders and solid tumors. Hematology (Am. Soc. Hematol. Educ. Program) (2003):372-397.
   Web of Science ®Google Scholar
• CHAMPLIN R, KHOURI I, ANDERLINI P et al.: Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications. Oncology (Williston Park) (2003) 17(1):94-100; discussion 103-107.
   PubMed Web of Science ®Google Scholar
• MIELCAREK M, SANDMAIER BM, MALONEY DG et al.: Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives. J. Clin. Immunol. (2002) 22(2):70-74.
   PubMed Web of Science ®Google Scholar
• CHAO NJ, LIU CX, ROONEY B et al.: Nonmyeloablative regimen preserves ‘niches’ allowing for peripheral expansion of donor T-cells. Biol. Blood Marrow Transplant. (2002) 8(5):249-256.
   PubMed Web of Science ®Google Scholar
• SLAVIN S, OR R, AKER M et al.: Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals. Cancer Chemother. Pharmacol. (2001) 48(Suppl. 1):S79-S84.
   PubMed Web of Science ®Google Scholar
• ANDREANI M, NESCI S, LUCARELLI G et al.: Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant. (2000) 25(4):401-404.
   PubMed Web of Science ®Google Scholar
• SCHRIER SL, ANGELUCCI E: New strategies in the treatment of the thalassemias. Annu. Rev. Med. (2005) 56:157-171.
   PubMed Web of Science ®Google Scholar
• LUCARELLI G, ANDREANI M, ANGELUCCI E: The cure of thalassemia by bone marrow transplantation. Blood Rev. (2002) 16(2):81-85.
   PubMed Web of Science ®Google Scholar
• MINIERO R, ROCHA V, SARACCO P et al.: Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord. Bone Marrow Transplant. (1998) 22(Suppl. 1):S78-S79.
   PubMed Web of Science ®Google Scholar
• STORB RF, CHAMPLIN R, RIDDELL SR et al.: Non-myeloablative transplants for malignant disease. Hematology (Am. Soc. Hematol. Educ. Program) (2001):375-391.
   PubMedGoogle Scholar
• VAN BESIEN K, BARTHOLOMEW A, STOCK W et al.: Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. Bone Marrow Transplant. (2000) 26(4):445-449.
   PubMed Web of Science ®Google Scholar
• SHENOY S, GROSSMAN WJ, DIPERSIO J et al.: A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant. (2005) 35(4):345-352.
   PubMed Web of Science ®Google Scholar
• SCHLEUNING M, STOETZER O, WATERHOUSE C et al.: Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. Exp. Hematol. (2002) 30(1):7-10.
   PubMed Web of Science ®Google Scholar
• KRISHNAMURTI L, BLAZAR BR, WAGNER JE: Bone marrow transplantation without myeloablation for sickle cell disease. N. Engl. J. Med. (2001) 344(1):68.
   PubMed Web of Science ®Google Scholar
• HONGENG S, CHUANSUMRIT A, HATHIRAT P et al.: Full chimerism in nonmyeloablative stem cell transplantation in a beta-thalassemia major patient (class 3 Lucarelli). Bone Marrow Transplant. (2002) 30(6):409-410.
   PubMed Web of Science ®Google Scholar
• IANNONE R, CASELLA JF, FUCHS EJ et al.: Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol. Bone Marrow Transplant. (2003) 9(8):519-528.
   Google Scholar
• HORAN JT, LIESVELD JL, FENTON P, BLUMBERG N, WALTERS MC: Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant. (2005) 35(2):171-177.
   PubMed Web of Science ®Google Scholar
• WOOLFREY AE, PULSIPHER MA, STORB R: Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children. Int. J. Hematol. (2002) 76(Suppl. 2):271-277.
   PubMed Web of Science ®Google Scholar
• KRISHNAMURTI L, WU CJ, BAKER KS, WAGNER JE: Matched sibling donor hematopoietic cell transplantation for sickle cell disease using a reduced intensity conditioning regimen can lead to stable long term engraftment. Blood (2005) 106(11):Abstract 3172.
   PubMedGoogle Scholar
• DODERO A, CARRABBA M, MILANI R et al.: Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed. Exp. Hematol. (2005) 33(8):920-927.
   PubMed Web of Science ®Google Scholar
• CHAKRABARTI S, HALE G, WALDMANN H: Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here? Transplant. Proc. (2004) 36(5):1225-1227.
   PubMed Web of Science ®Google Scholar
• AVIVI I, CHAKRABARTI S, KOTTARIDIS P et al.: Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. Bone Marrow Transplant. (2004) 34(2):137-142.
   PubMed Web of Science ®Google Scholar
• KEAN LS, MANCI EA, PERRY J et al.: Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease. Blood (2003) 102(13):4582-4593.
   PubMed Web of Science ®Google Scholar
• IANNONE R, LUZNIK L, ENGSTROM LW et al.: Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia. Blood (2001) 97(12):3960-3965.
   PubMed Web of Science ®Google Scholar
• WU CJ, KRISHNAMURTI L, KUTOK JL et al.: Evidence for ineffective erythropoiesis in severe sickle cell disease. Blood (2005) 106(10):3639-3645.
   PubMed Web of Science ®Google Scholar
• CHAKRAVERTY R, PEGGS K, CHOPRA R et al.: Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood (2002) 99(3):1071-1078.
   PubMed Web of Science ®Google Scholar
• ADAMKIEWICZ TV, MEHTA PS, BOYER MW et al.: Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant. (2004) 34(5):405-411.
   PubMed Web of Science ®Google Scholar
• WERNER E, YANOVICH S, RUBINSTEIN P, KURTZBERG J: Unrelated placental cord blood transplantation in a patient with sickle cell disease and acute non-lymphocytic leukemia. Blood (1997) 90:399b.
   Web of Science ®Google Scholar
• LA NASA G, GIARDINI C, ARGIOLU F et al.: Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood (2002) 99(12):4350-4356.
   PubMed Web of Science ®Google Scholar
• POWARS DR, CHAN LS, HITI A, RAMICONE E, JOHNSON C: Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) (2005) 84(6):363-376.
   PubMed Web of Science ®Google Scholar
• GLADWIN MT, SACHDEV V, JISON ML et al.: Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med. (2004) 350(9):886-895.
   PubMed Web of Science ®Google Scholar
• KRISHNAMURTI L, ABEL S, MAIERS M, FLESCH S: Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplant. (2003) 31(7):547-550.
   PubMed Web of Science ®Google Scholar
• ADAMKIEWICZ TV, BOYER MW, BRAY R, HAIGHT A, YEAGER AM: Identification of unrelated cord blood units for hematopoietic stem cell transplantation in children with sickle cell disease. J. Pediatr. Hematol. Oncol. (2006) 28(1):29-32.
   PubMed Web of Science ®Google Scholar
• MYASKOVSKY L, SWITZER GE, DEW MA et al.: The association of donor center characteristics with attrition from the national marrow donor registry. Transplantation (2004) 77(6):874-880.
   PubMed Web of Science ®Google Scholar
• FLOMENBERG N, BAXTER-LOWE LA, CONFER D et al.: Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood (2004) 104(7):1923-1930.
   PubMed Web of Science ®Google Scholar
• FLEISCHHAUER K, LOCATELLI F, ZECCA M et al.: Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood (2006) 107(7):2984-2992.
   PubMed Web of Science ®Google Scholar
• REED W, SMITH R, DEKOVIC F et al.: Comprehensive banking of sibling donor cord blood for children with malignant and nonmalignant disease. Blood (2003) 101(1):351-357.
   PubMed Web of Science ®Google Scholar
• BRICHARD B, VERMYLEN C, NINANE J, CORNU G: Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J. Pediatr. (1996) 128(2):241-243.
   PubMed Web of Science ®Google Scholar
• GORE L, LANE PA, QUINONES RR, GILLER RH: Successful cord blood transplantation for sickle cell anemia from a sibling who is human leukocyte antigen-identical: implications for comprehensive care. J. Pediatr. Hematol. Oncol. (2000) 22(5):437-440.
   PubMed Web of Science ®Google Scholar
• LOCATELLI F, ROCHA V, REED W et al.: Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood (2003) 101(6):2137-2143.
   PubMed Web of Science ®Google Scholar
• REED W, SMITH R, DEKOVIC F et al.: Comprehensive banking of sibling donor cord blood for children with malignant and non-malignant disease. Blood (2002) 101(1):351-357.
   PubMed Web of Science ®Google Scholar
• WALTERS MC, QUIROLO L, TRACHTENBERG ET et al.: Sibling donor cord blood transplantation for thalassemia major: experience of the sibling donor cord blood program. Ann. NY Acad. Sci. (2005) 1054:206-213.
   PubMed Web of Science ®Google Scholar
• BARKER JN, WEISDORF DJ, WAGNER JE: Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N. Engl. J. Med. (2001) 344(24):1870-1871.
   PubMed Web of Science ®Google Scholar
• WALTERS MC, SULLIVAN KM, BERNAUDIN F et al.: Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood (1995) 85(4):879-884.
   PubMed Web of Science ®Google Scholar
• ABBOUD M, KLETZEL M, MILLER S et al.: Bone marrow transplantation for sickle cell disease. Blood (1997) 90(10 Suppl. 1):229a.
   Web of Science ®Google Scholar
• SLAVIN S, NAGLER A, NAPARSTEK E et al.: Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood (1998) 91(3):756-763.
   PubMed Web of Science ®Google Scholar